MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx total assets
Total assets on the balance sheet at the end of each period.
MiMedx's total assets was $264.55M at Sep 30, 2026. For fiscal 2025 it was $342.65M, up 29.8% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $342.65M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $342.65M | +29.8% |
| FY2024 | Dec 31, 2024 | $263.92M | +10.4% |
| FY2023 | Dec 31, 2023 | $239.05M | +39.4% |
| FY2022 | Dec 31, 2022 | $171.43M | -8.8% |
| FY2021 | Dec 31, 2021 | $187.93M | -7.0% |
| FY2020 | Dec 31, 2020 | $202.03M | +20.9% |
| FY2019 | Dec 31, 2019 | $167.17M | +36.1% |
| FY2018 | Dec 31, 2018 | $122.84M | +1.3% |
| FY2017 | Dec 31, 2017 | $121.26M | +3.4% |
| FY2016 | Dec 31, 2016 | $117.27M | -13.7% |
| FY2015 | Dec 31, 2015 | $135.91M | +24.4% |
| FY2014 | Dec 31, 2014 | $109.26M | +29.0% |
| FY2013 | Dec 31, 2013 | $84.69M | +140.7% |
| FY2012 | Dec 31, 2012 | $35.18M | +29.8% |
| FY2011 | Dec 31, 2011 | $27.10M | +268.5% |
| FY2010 | Dec 31, 2010 | $7.35M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $264.55M | -17.1% |
| Q2 FY2026 | Jun 30, 2026 | $281.00M | -3.5% |
| Q1 FY2026 | Mar 31, 2026 | $308.68M | +14.1% |
| Q4 FY2025 | Dec 31, 2025 | $342.65M | +29.8% |
| Q3 FY2025 | Sep 30, 2025 | $318.99M | +30.8% |
| Q2 FY2025 | Jun 30, 2025 | $291.11M | +26.5% |
| Q1 FY2025 | Mar 31, 2025 | $270.42M | +22.0% |
| Q4 FY2024 | Dec 31, 2024 | $263.92M | +10.4% |
| Q3 FY2024 | Sep 30, 2024 | $243.89M | +29.0% |
| Q2 FY2024 | Jun 30, 2024 | $230.18M | +30.5% |
| Q1 FY2024 | Mar 31, 2024 | $221.68M | +31.8% |
| Q4 FY2023 | Dec 31, 2023 | $239.05M | +39.4% |
| Q3 FY2023 | Sep 30, 2023 | $189.02M | +9.4% |
| Q2 FY2023 | Jun 30, 2023 | $176.38M | +4.6% |
| Q1 FY2023 | Mar 31, 2023 | $168.16M | -3.6% |
| Q4 FY2022 | Dec 31, 2022 | $171.43M | -8.8% |
| Q3 FY2022 | Sep 30, 2022 | $172.80M | -4.3% |
| Q2 FY2022 | Jun 30, 2022 | $168.67M | -9.9% |
| Q1 FY2022 | Mar 31, 2022 | $174.44M | -8.6% |
| Q4 FY2021 | Dec 31, 2021 | $187.93M | -7.0% |
| Q3 FY2021 | Sep 30, 2021 | $180.52M | -15.4% |
| Q2 FY2021 | Jun 30, 2021 | $187.15M | +24.0% |
| Q1 FY2021 | Mar 31, 2021 | $190.81M | +20.1% |
| Q4 FY2020 | Dec 31, 2020 | $202.03M | +20.9% |
| Q3 FY2020 | Sep 30, 2020 | $213.32M | +19.0% |
| Q2 FY2020 | Jun 30, 2020 | $150.91M | -11.4% |
| Q1 FY2020 | Mar 31, 2020 | $158.91M | +47.9% |
| Q4 FY2019 | Dec 31, 2019 | $167.17M | +36.1% |
| Q3 FY2019 | Sep 30, 2019 | $179.27M | +47.8% |
| Q2 FY2019 | Jun 30, 2019 | $170.31M | -4.7% |
| Q1 FY2019 | Mar 31, 2019 | $107.44M | -46.2% |
| Q4 FY2018 | Dec 31, 2018 | $122.84M | -34.8% |
| Q4 FY2017 | Dec 31, 2017 | $121.26M | +3.4% |
| Q3 FY2017 | Sep 30, 2017 | $178.71M | – |
| Q2 FY2017 | Jun 30, 2017 | $199.87M | – |
| Q1 FY2017 | Mar 31, 2017 | $188.49M | – |
| Q4 FY2016 | Dec 31, 2016 | $117.27M | – |
See a number that looks wrong?